HOLOGIC INC (HOLX)
US4364401012 - Common Stock
We assign a fundamental rating of 6 out of 10 to HOLX. HOLX was compared to 187 industry peers in the Health Care Equipment & Supplies industry. HOLX gets an excellent profitability rating and is at the same time showing great financial health properties. HOLX has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
HOLX had positive earnings in the past year.
HOLX had a positive operating cash flow in the past year.
HOLX had positive earnings in each of the past 5 years.
HOLX had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
Looking at the Return On Assets, with a value of 8.62%, HOLX belongs to the top of the industry, outperforming 89.78% of the companies in the same industry.
Looking at the Return On Equity, with a value of 15.39%, HOLX belongs to the top of the industry, outperforming 90.32% of the companies in the same industry.
HOLX's Return On Invested Capital of 9.48% is amongst the best of the industry. HOLX outperforms 89.25% of its industry peers.
HOLX had an Average Return On Invested Capital over the past 3 years of 11.66%. This is above the industry average of 8.19%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.62% | ||
| ROE | 15.39% | ||
| ROIC | 9.48% |
ROA(3y)9.32%
ROA(5y)12.89%
ROE(3y)17.06%
ROE(5y)27.35%
ROIC(3y)11.66%
ROIC(5y)15.25%
1.3 Margins
HOLX's Profit Margin of 19.59% is amongst the best of the industry. HOLX outperforms 93.01% of its industry peers.
HOLX's Profit Margin has declined in the last couple of years.
With an excellent Operating Margin value of 24.07%, HOLX belongs to the best of the industry, outperforming 94.62% of the companies in the same industry.
HOLX's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 56.25%, HOLX is in line with its industry, outperforming 52.15% of the companies in the same industry.
HOLX's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 24.07% | ||
| PM (TTM) | 19.59% | ||
| GM | 56.25% |
OM growth 3Y-18.26%
OM growth 5Y7.36%
PM growth 3Y-16.15%
PM growth 5YN/A
GM growth 3Y-5.85%
GM growth 5Y1.6%
2. Health
2.1 Basic Checks
HOLX has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, HOLX has less shares outstanding
Compared to 5 years ago, HOLX has less shares outstanding
Compared to 1 year ago, HOLX has an improved debt to assets ratio.
2.2 Solvency
The Debt to FCF ratio of HOLX is 2.21, which is a good value as it means it would take HOLX, 2.21 years of fcf income to pay off all of its debts.
HOLX's Debt to FCF ratio of 2.21 is amongst the best of the industry. HOLX outperforms 87.63% of its industry peers.
HOLX has a Debt/Equity ratio of 0.49. This is a healthy value indicating a solid balance between debt and equity.
HOLX's Debt to Equity ratio of 0.49 is on the low side compared to the rest of the industry. HOLX is outperformed by 61.83% of its industry peers.
Although HOLX does not score too well on debt/equity it has very limited outstanding debt, which is well covered by the FCF. We will not put too much weight on the debt/equity number as it may be because of low equity, which could be a consequence of a share buyback program for instance. This needs to be investigated.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.49 | ||
| Debt/FCF | 2.21 | ||
| Altman-Z | N/A |
ROIC/WACC1.07
WACC8.84%
2.3 Liquidity
HOLX has a Current Ratio of 3.69. This indicates that HOLX is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 3.69, HOLX is in the better half of the industry, outperforming 64.52% of the companies in the same industry.
HOLX has a Quick Ratio of 3.03. This indicates that HOLX is financially healthy and has no problem in meeting its short term obligations.
HOLX has a Quick ratio of 3.03. This is in the better half of the industry: HOLX outperforms 64.52% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.69 | ||
| Quick Ratio | 3.03 |
3. Growth
3.1 Past
HOLX shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 3.29%.
The Earnings Per Share has been growing by 10.83% on average over the past years. This is quite good.
Looking at the last year, HOLX shows a decrease in Revenue. The Revenue has decreased by 0.00% in the last year.
Measured over the past years, HOLX shows a small growth in Revenue. The Revenue has been growing by 3.66% on average per year.
EPS 1Y (TTM)3.29%
EPS 3Y-21.36%
EPS 5Y10.83%
EPS Q2Q%13.48%
Revenue 1Y (TTM)0%
Revenue growth 3Y-10.56%
Revenue growth 5Y3.66%
Sales Q2Q%4.51%
3.2 Future
HOLX is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 8.34% yearly.
The Revenue is expected to grow by 5.85% on average over the next years.
EPS Next Y7.62%
EPS Next 2Y8.65%
EPS Next 3Y8.84%
EPS Next 5Y8.34%
Revenue Next Year4.32%
Revenue Next 2Y5.1%
Revenue Next 3Y5.41%
Revenue Next 5Y5.85%
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 19.36, the valuation of HOLX can be described as rather expensive.
Compared to the rest of the industry, the Price/Earnings ratio of HOLX indicates a rather cheap valuation: HOLX is cheaper than 88.17% of the companies listed in the same industry.
HOLX's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 29.29.
With a Price/Forward Earnings ratio of 17.99, HOLX is valued on the expensive side.
HOLX's Price/Forward Earnings ratio is rather cheap when compared to the industry. HOLX is cheaper than 86.02% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 24.01, HOLX is valued a bit cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.36 | ||
| Fwd PE | 17.99 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, HOLX is valued cheaply inside the industry as 86.56% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, HOLX is valued cheaper than 94.62% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 16.02 | ||
| EV/EBITDA | 14.36 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates HOLX does not grow enough to justify the current Price/Earnings ratio.
The excellent profitability rating of HOLX may justify a higher PE ratio.
PEG (NY)2.54
PEG (5Y)1.79
EPS Next 2Y8.65%
EPS Next 3Y8.84%
5. Dividend
5.1 Amount
HOLX does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
HOLOGIC INC
NASDAQ:HOLX (11/22/2024, 8:00:00 PM)
Premarket: 78 -0.97 (-1.23%)78.97
+0.25 (+0.32%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap18.34B
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.36 | ||
| Fwd PE | 17.99 | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)2.54
PEG (5Y)1.79
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.62% | ||
| ROE | 15.39% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | 24.07% | ||
| PM (TTM) | 19.59% | ||
| GM | 56.25% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.44
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.49 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 3.69 | ||
| Quick Ratio | 3.03 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)3.29%
EPS 3Y-21.36%
EPS 5Y
EPS Q2Q%
EPS Next Y7.62%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)0%
Revenue growth 3Y-10.56%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y